Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03673293 · ClinicalTrials.gov registry record
Measuring Postoperative Mobility, Gait Symmetry and Feedback Following TJA
A clinical trial of Total Joint Arthroplasty, sponsored by University of Utah.
- Completed
- Registry status
- 58
- Enrollment target
- 1
- Study location
NCT03673293: Completed study of Total Joint Arthroplasty, sponsored by University of Utah.
NCT03673293 is a study of Total Joint Arthroplasty that has completed, run by University of Utah. The registered enrollment target is 58 participants, below the 448-participant average among 3 other Total Joint Arthroplasty trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03673293, a study of Total Joint Arthroplasty, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this study are: 1. The investigators plan to evaluate and validate the use of a novel wireless insole device (Loadsol) that provides real-time biofeedback on post-operative mobility and weight bearing following total joint arthroplasty. 2. The investigators plan to utilize the wireless insole device to determine if biofeedback is sufficient for improving gait symmetry following total joint arthroplasty. 3. The investigators plan to determine if there is a correlation between patient reported outcomes and measured postoperative weight bearing.
Primary Outcome
Gait analysis of vertical ground reaction forces generated while performing routine exercises
Conditions Studied
Study Locations (1)
Utah
- University of Utah Orthopaedic Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2018-05-05 |
| Est. Completion | 2025-08-08 |
What the finished NCT03673293 record still lists
NCT03673293 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 448-participant average among 3 other Total Joint Arthroplasty trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Total Joint Arthroplasty appearing as the primary indexed condition, and to 0 interventions.
NCT03673293 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT03673293 about?
NCT03673293 is a clinical study titled "Measuring Postoperative Mobility, Gait Symmetry and Feedback Following TJA". The objectives of this study are: 1. The investigators plan to evaluate and validate the use of a novel wireless insole device (Loadsol) that provides real-time biofeedback on post-operative mobility and weight bearing following total joint arthroplasty. 2. The investigators plan to utilize the wir...
What is the current status of trial NCT03673293?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2018-05-05. Estimated completion is 2025-08-08.
What conditions does trial NCT03673293 study?
This clinical trial studies the following conditions: Total Joint Arthroplasty.
Who is sponsoring clinical trial NCT03673293?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03673293 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Joint Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI